Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

The Current Evidence-Based Medicine Landscape

The Current Evidence-Based Medicine Landscape

This reference guide identifies and documents all relevant organizations, activities, proposals, and key individuals associated with the evidence movement in the U.S., including anything of note under the rubric of evidence-based medicine (EBM), comparative effectiveness, and health (or medical) technology assessment (HTA), among others.

Newsletter Volume

E.V.I.dently December 2014

NPC MessageHave a Great Research Idea? We Might Have a Grant for That.When we hear from a wide range of health care stakeholders, it provides us with...
Blog Post

CER Tweets of the Week: CMS Proposing Rule to Improve ACOs, PCORI Funds Hepatitis C Research (December 8-12)

This week, comparative effectiveness research (CER) stakeholders tweeted news about two entities that resulted from the Affordable Care Act—...
Blog Post

CER Tweets of the Week: NPC Launches New RFP for Innovative Research, PCORI Opens Comment Period on Research D&I Framework & Toolkit (December 1-5)

This week, comparative effectiveness research (CER) stakeholders tweeted about research opportunities. AcademyHealth’s EDM Forum (@edm_ah) shared the...
Blog Post

CER Tweets of the Week: Input on PCORI Workshop, CER Collaborative Resources (November 24-28)

What are comparative effectiveness research (CER) stakeholders tweeting about? The Patient-Centered Outcomes Research Institute (@PCORI) asked for...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Press Release

NPC, UMD Study: Factors That Cause Different Treatment Responses Are Not Well Understood or Studied

Washington, DC, November 4, 2013—Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react...
Commentary and Testimony Page

NPC Comments on PCORI Proposal for Peer Review of Primary Research and Public Release of Research Findings

November 7, 2014Dr. Joe SelbyExecutive DirectorPatient-Centered Outcomes Research Institute1828 L St., NW, Suite 900Washington, DC 20036Dear Dr....
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
YouTube Videos

Health Technology Assessments and Specialty Medications

David Grainger, senior director, global public policy, Eli Lilly and Company, says that there are often challenges in conducting health technology...
YouTube Videos

Differences in Global Health Technology Assessment

David Grainger, senior director, global public policy, Eli Lilly and Company, describes how health technology assessment (HTA) informs policy and...
YouTube Videos

Incorporating Patient Views Into Health Technology Assessments

David Grainger, senior director, global public policy, Eli Lilly and Company, explains that many health technology assessments are incorporating...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
Blog Post

CER Tweets of the Week: CMS Proposing Rule to Improve ACOs, PCORI Funds Hepatitis C Research (December 8-12)

This week, comparative effectiveness research (CER) stakeholders tweeted news about two entities that resulted from the Affordable Care Act—...
Blog Post

CER Tweets of the Week: NPC Launches New RFP for Innovative Research, PCORI Opens Comment Period on Research D&I Framework & Toolkit (December 1-5)

This week, comparative effectiveness research (CER) stakeholders tweeted about research opportunities. AcademyHealth’s EDM Forum (@edm_ah) shared the...
Blog Post

CER Tweets of the Week: Input on PCORI Workshop, CER Collaborative Resources (November 24-28)

What are comparative effectiveness research (CER) stakeholders tweeting about? The Patient-Centered Outcomes Research Institute (@PCORI) asked for...
Blog Post

CER Tweets of the Week: PCORI’s Selby to Speak at CTSI Symposium, PIPC Annual Forum; Cochrane Consumer Network Training (November 17-21)

Upcoming and past events garnered attention among comparative effectiveness research (CER) stakeholders this week. They tweeted about the University...

Research

  •  
  • 1 of 13
  • >

Commentary & Testimony